Regulation of cancer cell migration and bone metastasis by RANKL.
about
Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancerOsteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerThe role of RANK-ligand inhibition in cancer: the story of denosumabRANK-RANKL signalling in cancerMicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast DifferentiationBone metastases: When and how lung cancer interacts with boneDenosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsWhere Do Bone-Targeted Agents RANK in Breast Cancer Treatment?Targeting RANKL in metastasisβ2-Microglobulin-mediated signaling as a target for cancer therapyAnti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesImmune regulation of bone metastasisTargeting tumor-stromal interactions in bone metastasisReceptor activator of NF-κB ligand induces cell adhesion and integrin α2 expression via NF-κB in head and neck cancers.Osteoprotegerin in bone metastases: mathematical solution to the puzzleCancer Cell Colonisation in the Bone MicroenvironmentOsteoblasts Are the Centerpiece of the Metastatic Bone MicroenvironmentKey roles of the OPG-RANK-RANKL system in bone oncologyRANKL/RANK-beyond bonesInflammation and skeletal metastasisReceptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsMicroenvironmental regulation of metastasisThe extracellular matrix: a dynamic niche in cancer progressionTreatment of osseous metastases using the Spinal Tumor Ablation with Radiofrequency (STAR) system.Mechanistic Pathways of Sex Differences in Cardiovascular Disease.RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitroMetastasis: a therapeutic target for cancer.Role of denosumab in prostate cancer.Genetic polymorphism of the OPG gene associated with breast cancer.Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activationBone Metastases: An Overview.Role of RANK and Akt1 activation in human osteosarcoma progression: A clinicopathological study.Molecular mechanisms of bone metastasis and associated muscle weakness.Targeted treatments of bone metastases in patients with lung cancerPhytochemicals potently inhibit migration of metastatic breast cancer cellsComparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.Bone marrow endothelium-targeted therapeutics for metastatic breast cancerShedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.
P2860
Q24319970-FD032EC8-E2BD-4867-9FE5-DB7DBE38A751Q24605866-0796C97A-D098-42A4-B7F8-4061580BEA8FQ24633284-A9ED02C5-5EA2-49A0-B704-73C810219656Q26747442-67D9F3BF-39F4-4065-8F48-7BD04FBA7550Q26783571-1FCB95B0-111A-413F-9F5E-8BB15ACB3D10Q26823287-B3EF4377-A71E-48D7-94B4-7BDD82F22E1FQ26824762-9B239E97-1E55-468C-AE53-82770B7C4159Q26849473-790F7733-ABAF-4A7B-B4D0-F06158EAA0B4Q26849690-EDC29064-9A3D-4261-BF75-6D589A28048CQ26853735-AAB9B8B9-4330-4DFA-8BA5-F1948C8CFE42Q26863493-7A7F8DE3-C7A4-4925-8D2F-C283A9F7EF26Q27005871-C5C17A77-B545-4E11-AEF0-1A9E28BA04F4Q27024561-5EFBD23B-AC79-4558-B142-EC266612E74CQ27326719-8C7843E5-E496-4054-8B9F-2DD018B419ECQ27329714-E0E35849-024E-42D9-B283-F4D49B3B8A72Q28072561-4729A8D5-5D2E-4A6D-A52C-B7BBC358FB8FQ28077461-7F4709E8-A290-4CC3-B846-3B336942D7A5Q28287394-7E3D153E-E42E-4410-B768-91D66B4853F1Q28308042-0E1F8243-5885-4352-AA1C-84AB3ABE1884Q28396089-6CE82D33-FE7C-46DA-BAA9-29F605977C57Q28740575-6FC97EA7-C3AD-4B7C-AE41-82B8D57E7C6AQ29547660-8F8E2561-985A-41D5-9482-25064EB1313CQ29617793-4BE6CEB7-9EC6-4CCD-B516-B9DEBF43DB52Q30241914-AE8BCA67-CC8B-4AB9-8F59-0DB668C37913Q30241924-AF108D25-0200-44E8-B968-2C2F131F9FEFQ30419245-E535BBF5-DA05-4C97-8612-9941140B9A4BQ30439221-DD99ED85-07CC-4B20-A70F-99297B8D88BBQ30455154-FB0333D4-E996-4600-8FBC-9ADAB6C91B2BQ30534404-0D317888-3B34-40E3-8E71-FF5887137255Q33293423-F50D19BA-F70F-45A7-A8B9-6FB03F977ED3Q33642546-E70C619A-4B37-45B9-82DD-7859000CD987Q33727278-3CB21F85-88DE-45A8-8C45-8519B26C7B43Q33744585-8EAABA92-8A06-4746-92B5-9DBFB22A2308Q33758508-84E2D915-991B-442B-8F4C-7743FFEDF4C8Q33759713-F7B5A213-141A-4400-89E8-77524404E974Q33810248-1F358839-B87F-4889-AB5C-267E63B36DCEQ33829429-AA580B56-EA23-4E9C-954D-227144770D98Q33900327-6411FB8A-5FC2-403B-805D-7E7DB0A157FBQ33943576-43431693-5456-4772-8529-03520C3B7082Q33958982-716B4CAE-9988-43A6-987D-D8B139C8211D
P2860
Regulation of cancer cell migration and bone metastasis by RANKL.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Regulation of cancer cell migration and bone metastasis by RANKL.
@en
type
label
Regulation of cancer cell migration and bone metastasis by RANKL.
@en
prefLabel
Regulation of cancer cell migration and bone metastasis by RANKL.
@en
P2093
P50
P356
P1433
P1476
Regulation of cancer cell migration and bone metastasis by RANKL
@en
P2093
Carlo V Hojilla
D Holstead Jones
Evelyn Rubin
Ildiko Sarosi
Ivona Kozieradzki
Otto H Sanchez
Rama Khokha
Renu Sarao
Sean Morony
Stephen M Sims
P2888
P304
P356
10.1038/NATURE04524
P407
P577
2006-03-01T00:00:00Z
P5875
P6179
1000685998